scholarly article | Q13442814 |
P50 | author | Polly A Newcomb | Q89454622 |
P2093 | author name string | Amy Trentham-Dietz | |
John M Hampton | |||
Karen J Wernli | |||
Kathleen M Egan | |||
P2860 | cites work | Hormonal etiology of epithelial ovarian cancer, with a hypothesis concerning the role of androgens and progesterone | Q77636062 |
Menopausal hormone therapy and ovarian cancer risk in the National Institutes of Health-AARP Diet and Health Study Cohort | Q79182453 | ||
Lifetime recreational and occupational physical activity and risk of in situ and invasive breast cancer | Q79776018 | ||
Menopausal hormones and risk of ovarian cancer | Q80379715 | ||
Impact of hysterectomy on endometrial carcinoma rates in the United States | Q81481079 | ||
Hormone replacement therapy and invasive and borderline epithelial ovarian cancer risk | Q81648115 | ||
Combined estrogen-progestogen contraceptives and combined estrogen-progestogen menopausal therapy | Q81894621 | ||
Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results From the Women's Health Initiative randomized controlled trial | Q27860743 | ||
A prospective study of postmenopausal hormone use and ovarian cancer risk | Q28213056 | ||
Statistical methods in cancer research. Volume II--The design and analysis of cohort studies | Q29615413 | ||
Hormone replacement therapy after invasive ovarian serous cystadenocarcinoma treatment: the effect on survival | Q32000828 | ||
Hormone replacement therapy after epithelial ovarian cancer treatment. | Q33937559 | ||
National use of postmenopausal hormone therapy: annual trends and response to recent evidence | Q34288307 | ||
Ovarian cancer and hormone replacement therapy in the Million Women Study | Q34629811 | ||
Hormone replacement therapy and survival after surgery for ovarian cancer | Q35178365 | ||
Hormone replacement therapy and risk of epithelial ovarian cancer. | Q36619751 | ||
Effect of hysterectomy on incidence trends of endometrial and cervical cancer in Finland 1953-2010 | Q36695133 | ||
Expression of gonadotropin receptor and growth responses to key reproductive hormones in normal and malignant human ovarian surface epithelial cells | Q40780316 | ||
Utility of the National Death Index for ascertainment of mortality among cancer prevention study II participants | Q40885870 | ||
Effects of estrogen plus progestin on gynecologic cancers and associated diagnostic procedures: the Women's Health Initiative randomized trial | Q44602959 | ||
Hormonal factors and the risk of invasive ovarian cancer: a population-based case-control study | Q46151255 | ||
Weight change and risk of postmenopausal breast cancer (United States). | Q47235408 | ||
Estrogen replacement therapy and ovarian cancer mortality in a large prospective study of US women. | Q50672431 | ||
Statistical methods in cancer research. Volume I - The analysis of case-control studies. | Q52768696 | ||
Hormone replacement therapy formulations and risk of epithelial ovarian carcinoma. | Q53824136 | ||
Hormone replacement therapy and incidence of hormone-dependent cancers in the Norwegian Women and Cancer study. | Q55038814 | ||
Use of hormone replacement therapy before and after ovarian cancer diagnosis and ovarian cancer survival | Q57027279 | ||
Hormone replacement therapy and the risk of invasive epithelial ovarian cancer in Swedish women | Q57199859 | ||
A meta-analysis of estrogen replacement therapy and risk of epithelial ovarian cancer | Q64130667 | ||
Differences in risk factors for epithelial ovarian cancer by histologic type. Results of a case-control study | Q71270652 | ||
Estrogen replacement therapy and fatal ovarian cancer | Q72157255 | ||
Estrogen replacement therapy for ovarian carcinoma survivors: A randomized controlled trial | Q73004908 | ||
Hormone replacement therapy as a risk factor for epithelial ovarian cancer: results of a case-control study | Q73384879 | ||
Hysterectomy prevalence and adjusted cervical and uterine cancer rates in England and Wales | Q73761682 | ||
Menopausal hormone replacement therapy and risk of ovarian cancer | Q74460475 | ||
Estrogen replacement therapy and ovarian cancer | Q75231048 | ||
Hormone replacement therapy and the risk of epithelial ovarian carcinoma: a meta-analysis | Q77168041 | ||
P433 | issue | 6 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | ovarian cancer | Q172341 |
P304 | page(s) | 605-613 | |
P577 | publication date | 2008-02-09 | |
P1433 | published in | Cancer Causes & Control | Q325957 |
P1476 | title | Hormone therapy and ovarian cancer: incidence and survival | |
P478 | volume | 19 |
Q46300341 | Estrone sulfatase activity in patients with advanced ovarian cancer |
Q42754883 | Immunohistochemical analysis of 17β-hydroxysteroid dehydrogenase isozymes in human ovarian surface epithelium and epithelial ovarian carcinoma |
Q37532651 | Investigation of mammographic breast density as a risk factor for ovarian cancer |
Q92071291 | Menopausal Hormone Replacement Therapy and the Risk of Ovarian Cancer: A Meta-Analysis |
Q36039829 | Menopausal hormone therapy and mortality among women diagnosed with ovarian cancer in the NIH-AARP Diet and Health Study |
Q43864747 | Menopausal hormone therapy and risk of ovarian cancer in the European prospective investigation into cancer and nutrition |
Q97528612 | Menopausal hormone therapy prior to the diagnosis of ovarian cancer is associated with improved survival |
Q91690126 | Non-classical estrogen signaling in ovarian cancer improves chemo-sensitivity and patients outcome |
Q64079499 | Ovarian cancer in the world: epidemiology and risk factors |
Q37017056 | Ovarian cancer stroma: pathophysiology and the roles in cancer development |
Q40227579 | Premenopausal Hysterectomy and Risk of Ovarian Cancer in African-American Women |
Q39324480 | Reproductive and hormonal factors in relation to survival and platinum resistance among ovarian cancer cases |
Q36443891 | Reproductive factors and epithelial ovarian cancer survival in the EPIC cohort study |
Q34622294 | SGO White Paper on ovarian cancer: etiology, screening and surveillance |
Search more.